drug development - search results

Sumith A Kularatne, Vice President of Research & Development at On Target Laboratories discusses the scope of image-guided surgery in treating lung cancer

Alexander Flisch, Project Coordinator, Empa – Swiss Federal Laboratories for Materials Science and Technology outlines a new platform for cargo X-ray image interpretation training.

Professor Colin Suckling discusses chemistry-based innovation and research benefits that can be seen during our lifetimes. Many people have written off traditional sciences as having little value to the modern world. The real excitement in science is said to be in the big things like the Higgs boson and gravitational waves....

Sumith A Kularatne of On Target Laboratories, LLC highlights cancer immunotherapy as the treatment of the year to target cancer cells

Ramón Cacabelos of EuroEspes Biomedical Research Center details how the incorporation of pharmacogenomics to treat Alzheimer’s patients is crucial

Childhood obesity can cause major health problems in later life. Open Access Government highlights how Finland is tackling the growing health challenge

Mabel L. Rice, University of Kansas highlights specific language impairment and why it often goes unrecognised as health disorder

Professor Pierre S. Haddad shares the challenges of overcoming health inequality for Canadian indigenous populations and highlights solutions to the issue

Uterine fibroids represent a prevalent benign gynaecologic problem in the U.S, here Romana A. Nowak of the University of Illinois explains

Health promotion is the workplace is a key priority in the 21st Century, explains Jaana Laitinen of the Finnish Institute of Occupational Health

Antonino Tramonte, Managing Director, Swiss Institute for Regenerative Medicine outlines how regenerative medicine can help patients.

Head of the Europol Cybercrime Centre, Steve Wilson shares how his organisation is tackling cybercrime and explains why a collaborative approach is needed

Prof Colin J Suckling, University of Strathclyde's Department of Pure & Applied Chemistry, discusses heterocyclic chemistry.

Chief Executive Hilary Evans highlights how Alzheimer’s Research UK is helping advance dementia research, but warns there is still more to be done

Dr Mehis Pilv, CEO and business development lead at Genecode, discusses the strides being made in Parkinson's disease research Parkinson's disease is a slow but progressive neurodegenerative disorder. About 1% of people aged above 50 are affected worldwide. In Europe alone 1.2 million people suffer from Parkinson's disease, 127,000 of whom...

A prison officer pay boost announced by the Justice Secretary has been slammed as “divisive” and inadequate by the Prison Officers’ Association Prison officers at 31 prisons in London and the South East are set to get an immediate pay rise, according to the Ministry of Justice. Justice Secretary Elizabeth Truss...

Dr. Alexander Natz and Dr. Oliver Sude, EUCOPE outline the role small to medium sized innovative companies can play in developing pharmaceutical research

Gabriel Wikström, Minister for Health Care, Public Health and Sport, sets out the Swedish agenda to end AIDS by 2030 to Open Access Government Today we have the knowledge and tools to end AIDS by 2030, but to reach zero AIDS-related deaths, stop the HIV epidemic and prevent discrimination, knowledge...

AriSLA – The Italian Research Foundation for ALS, outlines strides made in ALS research in Italy over the last 10 years and work still needed to find a cure Amyotrophic lateral sclerosis (ALS) is the most common adult-onset neurodegenerative disease, characterised by progressive loss of upper and lower motor neurons...

Dr Sumith A Kularatne, vice-president of R&D at On Target Laboratories, explores the pros and cons of various existing treatments for prostate cancer Prostate cancer (PCa) is the second leading cause of cancer-related deaths in men, with about 1.1 million new cases and approximately 307,000 fatalities per year globally. This...